Local Biotech Exit: The Abexxa Biologics Story

Jon Weidanz and Debra Weidanz talk about the recent acquisition of their startup, Abexxa Biologics, by Boehringer Ingelheim. Local biotech companies has had recent streak of acquisitions, meet the founders of Abbexxa biologics, who represent the 1 of 6 big biotech acquisitions in the last 6 years. Abexxa Biologics is a biopharmaceutical company taking a new approach in the fields of oncology to develop the next generation of precision medicine.

Click here for more information!